Agios Pharmaceuticals Inc (AGIO)
34.54
-0.04
(-0.12%)
USD |
NASDAQ |
May 03, 16:00
34.54
0.00 (0.00%)
After-Hours: 20:00
Agios Pharmaceuticals Free Cash Flow: -314.56M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -314.56M |
| September 30, 2023 | -308.12M |
| June 30, 2023 | -299.99M |
| March 31, 2023 | -309.40M |
| December 31, 2022 | -314.36M |
| September 30, 2022 | -336.68M |
| June 30, 2022 | -350.45M |
| March 31, 2022 | -391.84M |
| December 31, 2021 | -413.06M |
| September 30, 2021 | -374.42M |
| June 30, 2021 | -362.67M |
| March 31, 2021 | -317.07M |
| December 31, 2020 | -304.86M |
| September 30, 2020 | -355.20M |
| June 30, 2020 | -369.41M |
| March 31, 2020 | -386.90M |
| December 31, 2019 | -382.65M |
| September 30, 2019 | -357.60M |
| June 30, 2019 | -336.95M |
| March 31, 2019 | -316.28M |
| December 31, 2018 | -311.41M |
| September 30, 2018 | -311.90M |
| June 30, 2018 | -324.66M |
| Date | Value |
|---|---|
| March 31, 2018 | -315.92M |
| December 31, 2017 | -289.86M |
| September 30, 2017 | -266.57M |
| June 30, 2017 | -239.29M |
| March 31, 2017 | -24.18M |
| December 31, 2016 | 28.65M |
| September 30, 2016 | 48.38M |
| June 30, 2016 | 72.72M |
| March 31, 2016 | -89.27M |
| December 31, 2015 | -97.11M |
| September 30, 2015 | -73.66M |
| June 30, 2015 | -69.64M |
| March 31, 2015 | -63.90M |
| December 31, 2014 | -61.57M |
| September 30, 2014 | -66.14M |
| June 30, 2014 | -57.12M |
| March 31, 2014 | -72.49M |
| December 31, 2013 | -57.69M |
| September 30, 2013 | -55.51M |
| June 30, 2013 | -52.97M |
| March 31, 2013 | -47.28M |
| December 31, 2012 | -51.02M |
Free Cash Flow Range, Past 5 Years
-413.06M
Minimum
Dec 2021
-299.99M
Maximum
Jun 2023
-346.64M
Average
-350.45M
Median
Jun 2022
Free Cash Flow Benchmarks
| Alnylam Pharmaceuticals Inc | 41.94M |
| Amgen Inc | 7.359B |
| Blueprint Medicines Corp | -452.91M |
| Corcept Therapeutics Inc | 126.90M |
| Ionis Pharmaceuticals Inc | -335.52M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -72.49M |
| Cash from Investing (Quarterly) | 95.51M |
| Cash from Financing (Quarterly) | 0.847M |
| Free Cash Flow Per Share (Quarterly) | -1.300 |
| Free Cash Flow to Equity (Quarterly) | -72.72M |
| Free Cash Flow Yield | -16.37% |